Real-time enrollment status for this her2 low breast carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:30 AM UTC
| NCT Number | NCT06224673 |
| Recruiting Status | Recruiting |
| Condition | HER2 Low Breast Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 36 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Laura Huppert, MD, BA |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 17, 2026: Clinical trial NCT06224673 is currently recruiting participants. This phase2 study for her2 low breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Laura Huppert, MD, BA. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06224673 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06224673 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.